ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Strategy on Patients with EGFR Mutation
New Therapeutic Strategies in Lung Cancers
◽
10.1007/978-3-319-06062-0_9
◽
2014
◽
pp. 133-145
Author(s):
Martin Früh
◽
Qing Zhou
◽
Linda Leung
◽
Tony Mok
Keyword(s):
Egfr Mutation
Download Full-text
Related Documents
Cited By
References
EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to Gefitinib
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70161-1
◽
2006
◽
Vol 2006
◽
pp. 228-229
Author(s):
N.H. Hanna
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Osimertinib beim nicht kleinzelligen Bronchialkarzinom mit EGFR-Mutation
TumorDiagnostik & Therapie
◽
10.1055/a-0596-8948
◽
2018
◽
Vol 39
(05)
◽
pp. 288-288
Keyword(s):
Egfr Mutation
Download Full-text
Der SUV im FDG-PET als prädiktiver Wert einer EGFR-Mutation beim nicht-kleinzelligen Lungenkarzinom
Pneumologie
◽
10.1055/s-0032-1302854
◽
2012
◽
Vol 66
(S 01)
◽
Cited By ~ 1
Author(s):
GJ Förster
◽
D Misch
◽
J Kollmeier
◽
T Köcer
◽
S Griff
◽
...
Keyword(s):
Fdg Pet
◽
Egfr Mutation
◽
Prädiktiver Wert
Download Full-text
Reduzierte Dosis von TKI führt nicht zu Wirkungsverlust bei Patienten mit aktivierender EGFR Mutation
Pneumologie
◽
10.1055/s-0034-1367950
◽
2014
◽
Vol 68
(S 01)
◽
Cited By ~ 1
Author(s):
N Reinmuth
◽
D Heigener
◽
T Goldmann
◽
M Reck
Keyword(s):
Egfr Mutation
Download Full-text
Multizentrische, randomisierte Doppelblindstudie mit Erlotinib plus Ramucirumab oder plus Plazebo bei metastasiertem nichtkleinzelligen Lungenkarzinom (NCSLC) mit EGFR-Mutation
Pneumologie
◽
10.1055/s-0037-1598342
◽
2017
◽
Vol 71
(S 01)
◽
pp. S1-S125
Author(s):
M Reck
◽
EB Garon
◽
O Juan
◽
E Nadal
◽
P Lee
◽
...
Keyword(s):
Egfr Mutation
Download Full-text
Langanhaltende Remission unter Afatinib bei NSCLC mit seltener Exon 18 EGFR-Mutation
Pneumologie
◽
10.1055/s-0037-1619264
◽
2018
◽
Vol 72
(S 01)
◽
pp. S55-S56
Author(s):
Z Syunyaeva
◽
K Kahnert
◽
D Kauffmann-Guerrero
◽
P Mertsch
◽
J Behr
◽
...
Keyword(s):
Egfr Mutation
Download Full-text
NSCLC Stadium III mit EGFR Mutation – erfolgreiche Induktionstherapie mit Afatinib
10.1055/s-0039-1678023
◽
2019
◽
Author(s):
S Rüdiger
◽
G Schmidtke-Schrezenmeier
◽
C Kropf-Sanchen
◽
S Feuerabendt
◽
J Wöhrle
◽
...
Keyword(s):
Egfr Mutation
Download Full-text
The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer
Case Medical Research
◽
10.31525/ct1-nct04206787
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Epidermal Growth Factor Receptor
◽
Egfr Mutation
◽
Growth Factor Receptor
◽
Sequential Therapy
◽
Nonsmall Cell Lung Cancer
◽
Line Treatment
◽
First Line
◽
Epidermal Growth
◽
First Line Treatment
Download Full-text
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
Case Medical Research
◽
10.31525/ct1-nct04248829
◽
2020
◽
Author(s):
Keyword(s):
Clinical Trial
◽
Egfr Mutation
◽
Locally Advanced
◽
Line Treatment
◽
First Line
◽
Metastatic Nsclc
◽
First Line Treatment
Download Full-text
Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions
Current Oncology
◽
10.3747//co.19.949
◽
2012
◽
Vol 19
(1)
◽
Author(s):
I. Karam
◽
B. Melosky
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Small Cell
◽
Second Line
◽
Small Cell Lung
◽
Negative Patient
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close